MP:0001876 | decreased inflammatory response | "less than expected response to injury, infection, or insult" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Map3k7tm1Mis/Map3k7tm1Mis,H2afvTg(Wnt1-cre)11Rth/0 Genetic Background: involves: C57BL/6J * CBA/J
|
MP:0003447 | reduced tumor growth/size | "less than expected development of tumorous growth when compared to controls" [anna:Anna Anagnostopoulos, Mouse Genome Informatics Curator, J:65383] |
Show
Allelic Composition: Map3k7tm1Mis/Map3k7tm1Mis,H2afvTg(Wnt1-cre)11Rth/0 Genetic Background: involves: C57BL/6J * CBA/J
|
MP:0003448 | altered tumor morphology | "changes in the expected pathology for a given tumor type compared to controls" [anna:Anna Anagnostopoulos, Mouse Genome Informatics Curator] |
Show
Allelic Composition: Map3k7tm1Mis/Map3k7tm1Mis,H2afvTg(Wnt1-cre)11Rth/0 Genetic Background: involves: C57BL/6J * CBA/J
|
MP:0004502 | decreased incidence of chemically-induced tumors | "lower than normal frequency of tumor incidence induced by one or more chemical carcinogens or mutagens" [MGI:smb "Susan M. Bello, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Map3k7tm1Mis/Map3k7tm1Mis,H2afvTg(Wnt1-cre)11Rth/0 Genetic Background: involves: C57BL/6J * CBA/J
|
MP:0008566 | increased interferon-gamma secretion | "increase in the production or release of the major interferon produced by mitogenically or antigenically stimulated lymphocytes that is involved in immunoregulation" [MESH:D12.644.276.374.440.893] |
Show
Allelic Composition: Map3k7tm1Mis/Map3k7tm1Mis,H2afvTg(Wnt1-cre)11Rth/0 Genetic Background: involves: C57BL/6J * CBA/J
|
MP:0008568 | abnormal interleukin secretion | "anomaly in the production or cellular release of soluble factors which stimulate growth-related activities of leukocytes and other cell types, that can act to enhance cell proliferation and differentiation, DNA synthesis, secretion of other biologically active molecules and responses to immune and inflammatory stimuli" [MESH:D12.644.276.374.465] |
Show
Allelic Composition: Map3k7tm1Mis/Map3k7tm1Mis,H2afvTg(Wnt1-cre)11Rth/0 Genetic Background: involves: C57BL/6J * CBA/J
|
MP:0008654 | increased interleukin-1 alpha secretion | "increase in the production or release of an interleukin-1 subtype that occurs as a membrane-bound pro-protein form that is cleaved by proteases to form a secreted mature form; both membrane-bound and secreted forms of interleukin-1alpha are biologically active" [MESH:D12.644.276.374.465.501.300] |
Show
Allelic Composition: Map3k7tm1Mis/Map3k7tm1Mis,H2afvTg(Wnt1-cre)11Rth/0 Genetic Background: involves: C57BL/6J * CBA/J
|
MP:0008681 | increased interleukin-17 secretion | "increase in the production or release of a proinflammatory cytokine produced primarily by T-cells or their precursors" [MESH:D12.644.276.374.465.517] |
Show
Allelic Composition: Map3k7tm1Mis/Map3k7tm1Mis,H2afvTg(Wnt1-cre)11Rth/0 Genetic Background: involves: C57BL/6J * CBA/J
|
MP:0008687 | increased interleukin-2 secretion | "increase in the production or release of a soluble substance elaborated by antigen- or mitogen-stimulated T-cells which induces DNA synthesis in naive lymphocytes" [MESH:D12.644.276.374.465.502] |
Show
Allelic Composition: Map3k7tm1Mis/Map3k7tm1Mis,H2afvTg(Wnt1-cre)11Rth/0 Genetic Background: involves: C57BL/6J * CBA/J
|